Please note that we’ve reached capacity for this meeting and registration is now closed. Thank you for your interest. We truly appreciate it and hope to see you at one of our upcoming meetings! Feel free to explore future opportunities here.
In-Person Access Only | 9.75 CE/CME Credits & MOC Points
Total Health's 2025 ASCO Direct™ Honolulu Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Program Chairs
Dr. Carney: President, Hawaii Society of Clinical Oncology
Dr. Ueno: Director, University of Hawai'i Cancer Center
Dr. Yamauchi: Clinical Education Leader, University of Hawai'i Cancer Center
Conference Agenda
Saturday, June 28, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome and Hawaii State of Cancer Care
8:40 AM
Colorectal Cancer Jared Acoba, MD | University of Hawai'i Cancer Center
9:10 AM
Non-Colorectal Cancer Elizabeth Nakasone, MD, PhD | University of Hawai'i Cancer Center
9:40 AM
Q&A and Local Clinical Trials Elizabeth Nakasone, MD, PhD | University of Hawai'i Cancer Center Jared Acoba, MD | University of Hawai'i Cancer Center
9:55 AM
Breakfast and Exhibits
10:10 AM
Non-CME Breakfast - Regeneron - BRINGING THE DATA TO LIFE: Learnings from Clinical Trials to Clinical Practice on a Treatment Option for Advanced NSCLC
Chaitali Nangia, MD | Hoag Medical Center, Chan Soon-Shiong Institute for Medicine
10:55 AM
Small Cell Lung Cancer Millie Das, MD | Stanford University
11:25 AM
Non-Small Cell Lung Cancer Evan Wu, MD | Hawai'i Pacific Health
11:55 PM
Head and Neck Cancer Tirrell Johnson, MD | Orlando Health
12:15 PM
Panel Discussion and Q&A Millie Das, MD | Stanford University Evan Wu, MD | Hawai'i Pacific Health Tirrell Johnson, MD | Orlando Health
12:30 PM
Lunch and Exhibits
12:45 PM
Non-CME Lunch - Pfizer - Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer
David B. Page, MD | Providence Cancer Institute
1:30 PM
Housekeeping and Survey
1:40 PM
Gynecologic Cancer John Chan, MD | California Pacific Medical Center
2:05 PM
Q&A and Local Clinical Trials John Chan, MD | California Pacific Medical Center
2:20 PM
Leukemia Stephanie Si Lim, MD, MBA | University of Hawai'i Cancer Center
2:40 PM
Lymphoma Craig Boddy, MD | Hawai'i Pacific Health
3:00 PM
Multiple Myeloma Jeff Matous, MD | Colorado Blood Cancer Institute
3:20 PM
Q&A and Local Clinical Trials Stephanie Si Lim, MD, MBA | University of Hawai'i Cancer Center Jeff Matous, MD | Colorado Blood Cancer Institute Craig Boddy, MD | Hawai'i Pacific Health
3:35 PM
Networking Reception
4:35 PM
Adjourn
Sunday, June 29, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Welcome and Opening Remarks
8:35 AM
GU Cancer (Prostate, Testicular, Penile)
Eric Seifter, MD | Johns Hopkins School of Medicine
8:50 AM
GU Cancer (Kidney and Bladder)
Alexander Wei, MD | Columbia University Irving Medical Center
9:20 AM
Q&A and Local Clinical Trials Eric Seifter, MD | Johns Hopkins School of Medicine
9:35 AM
Breakfast and Exhibits
9:50 AM
Non-CME Breakfast - Gilead - Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC
Rena Callahan, MD | David Geffen School of Medicine at UCLA
10:35 AM
Melanoma
Mohammed Kashani-Sabet, MD |California Pacific Medical Center
11:05 AM
Sarcomas
Shane Morita, MD, MBA, PhD, FACS | The Queens Medical Center
11:35 AM
Q&A and Local Clinical Trials
Shane Morita, MD, MBA, PhD, FACS | The Queens Medical Center
Mohammed Kashani-Sabet, MD |California Pacific Medical Center
11:50 AM
Survivorship Valerie Ferguson, NP | Hawaii Pacific Health
12:20 PM
Q&A and Local Clinical Trials Valerie Ferguson, NP | Hawaii Pacific Health
Sangeetha Reddy, MD | UT Southwestern
12:35 PM
Lunch and Exhibits
12:50 PM
Non-CME Lunch - Novartis - Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI in eBC and mBC
Eric Morales| Novartis
1:35 PM
Promising Emerging Drugs in Phase I Blessie Elizabeth Nelson MBBS, DMRT | The University of Texas MD Anderson Cancer Center
1:55 PM
Early-Stage Breast Cancer David Page, MD | Providence Cancer Institute
2:25 PM
Metastatic Breast Cancer
Eric Seifter, MD | Johns Hopkins School of Medicine
3:10 PM
Q&A and Local Clinical Trials Blessie Elizabeth Nelson MBBS, DMRT| The University of Texas MD Anderson Cancer Center David Page, MD | Providence Cancer Institute
Eric Seifter, MD | Johns Hopkins School of Medicine
3:25 PM
Adjourn
Agenda Subject To Change. All times are HST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 9.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 9.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 9.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program